Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · see citing works

Astrocyte-endothelial interactions at the blood-brain barrier

Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · see citing works

Structure and function of the blood–brain barrier

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,800 · see citing works

Stages in the development of Parkinson’s disease-related pathology

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works

Protein carbonyl groups as biomarkers of oxidative stress

Dalle‐Donne, I., Rossi, R., Giustarini, D., Milzani, A., & Colombo, R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00003-2 · Cited by 2,353 · see citing works

Two to tango: Regulation of Mammalian iron metabolism

Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · see citing works

Mitochondria, oxidative stress and cell death

Ott, M., Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0756-2 · Cited by 1,976 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

Iron, brain ageing and neurodegenerative disorders

Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · see citing works

A Medicinal Chemist’s Guide to Molecular Interactions

Bissantz, C., Kuhn, B., & Ståhl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100112j · Cited by 1,773 · see citing works

Copper Active Sites in Biology

Solomon, E. I., Heppner, D. E., Johnston, E. M., Ginsbach, J. W., Cirera, J., Qayyum, M. F., Kieber‐Emmons, M. T., Kjaergaard, C. H., Hadt, R. G., & Tian, L. (2014) · Chemical Reviews · doi:10.1021/cr400327t · Cited by 1,763 · see citing works

The Protective Role of Melanin Against UV Damage in Human Skin ^†

Brenner, M., & Hearing, V. J. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00226.x · Cited by 1,741 · see citing works

Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures

Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007560 · Cited by 1,542 · see citing works

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · see citing works

Alpha-synuclein and neurodegenerative diseases

Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,402 · see citing works

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works

The therapeutic potential of monoamine oxidase inhibitors

Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,374 · see citing works

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 2× · see citing works

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein

Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103 · see citing works

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072 · see citing works

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · cited 2× · see citing works

The physical and chemical properties of eumelanin

Meredith, P., & Sarna, T. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00345.x · Cited by 1,033 · see citing works

Increased nigral iron content in postmortem parkinsonian brain

Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963 · see citing works

Protein carbonylation in human diseases

Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., & Milzani, A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00031-5 · Cited by 961 · see citing works

Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis

Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · see citing works

The labile iron pool: characterization, measurement, and participation in cellular processes1 1This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.

Kakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01006-7 · Cited by 839 · see citing works

Ascorbate regulation and its neuroprotective role in the brain

Rice, M. E. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01543-x · Cited by 835 · see citing works

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression

Gao, H., & Hong, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 822 · see citing works

Chemistry and biology of eukaryotic iron metabolism

Aisen, P. (2001) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804 · see citing works

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754 · see citing works

Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions

Catalá, A. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.09.004 · Cited by 745 · see citing works

Blood–brain barrier dysfunction in parkinsonian midbrain in vivo

Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733 · see citing works

Dopamine covalently modifies and functionally inactivates parkin

LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722 · see citing works

Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network

Muckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701 · see citing works

Polydopamine and Eumelanin: From Structure–Property Relationships to a Unified Tailoring Strategy

d’Ischia, M., Napolitano, A., Ball, V., Chen, C.-T., & Buehler, M. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar500273y · Cited by 668 · see citing works

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 652 · see citing works

Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis

Farrall, A., & Wardlaw, J. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.089 · Cited by 639 · see citing works

Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

Martínez‐Vicente, M., Tallóczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J. R., Mosharov, E. V., Hodara, R., Fredenburg, R. A., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 633 · see citing works

Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)

Ballard, P., Tetrud, J. W., & Langston, J. W. (1985) · Neurology · doi:10.1212/wnl.35.7.949 · Cited by 630 · see citing works

Forging a field: the golden age of iron biology.

Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623 · see citing works

Oligodendrocytes and myelination: The role of iron

Todorich, B., Pasquini, J. M., Garcia, C. I., Paez, P. M., & Connor, J. R. (2008) · Glia · doi:10.1002/glia.20784 · Cited by 615 · see citing works

A timeline for Parkinson's disease

Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594 · see citing works

Biology of Amyloid: Structure, Function, and Regulation

Greenwald, J., & Riek, R. (2010) · Structure · doi:10.1016/j.str.2010.08.009 · Cited by 573 · see citing works

Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations

Kachergus, J. M., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J. O., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J. C., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 536 · see citing works

Iron Deficiency Alters Brain Development and Functioning

Beard, J. (2003) · Journal of Nutrition · doi:10.1093/jn/133.5.1468s · Cited by 534 · see citing works

Labile iron pool: the main determinant of cellular response to oxidative stress

Kruszewski, M. K. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.08.004 · Cited by 529 · see citing works

A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe

Abbas, N., Lücking, C. B., Ricard, S., Dürr, A., Bonifati, V., Michele, G. D., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 529 · see citing works

Distinct Monoamine Oxidase A and B Populations in Primate Brain

Westlund, K. N., Denney, R. M., Kochersperger, L. M., Rose, R. M., & Abell, C. W. (1985) · Science · doi:10.1126/science.3875898 · Cited by 505 · see citing works

Chemistry of Mixed Melanogenesis—Pivotal Roles of Dopaquinone†

Ito, S., & Wakamatsu, K. (2007) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00238.x · Cited by 504 · see citing works

Protective and toxic roles of dopamine in Parkinson's disease

Segura‐Aguilar, J., Paris, I. B., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 499 · see citing works

Iron metabolism in the CNS: implications for neurodegenerative diseases

Rouault, T. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3453 · Cited by 496 · see citing works

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein Is Sensitive to Parkinson's Disease-Linked Mutations and Occurs by a Pore-like Mechanism

Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 485 · see citing works

Melanins and melanogenesis: Methods, standards, protocols

d'Ischia, M., Wakamatsu, K., Napolitano, A., Briganti, S., Garcia‐Borron, J., Kovacs, D., Meredith, P., Pezzella, A., Picardo, M., Sarna, T., et al. (2013) · Pigment Cell &amp; Melanoma Research · doi:10.1111/pcmr.12121 · Cited by 484 · see citing works

New trends in photobiology

Kollias, N., Sayre, R. M., Zeise, L., & Chedekel, M. R. (1991) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(91)80147-a · Cited by 482 · see citing works

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works

Advances in the genetics of Parkinson disease

Trinh, J., & Farrer, M. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 465 · see citing works

Structures for amyloid fibrils

Makin, O. S., & Serpell, L. C. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05025.x · Cited by 462 · see citing works

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles

Sulzer, D. L., Bogulavsky, J. J., Larsen, K. E., Behr, G. G., Karatekin, E., Kleinman, M. H., Turro, N. J., Krantz, D. E., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 460 · see citing works

Amorphous Semiconductor Switching in Melanins

McGinness, J. E., Corry, P. M., & Proctor, P. H. (1974) · Science · doi:10.1126/science.183.4127.853 · Cited by 447 · see citing works

Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445 · see citing works

Structure, function, and mechanism of ribonucleotide reductases

Kolberg, M., Strand, K. R., Graff, P., & Andersson, K. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.02.007 · Cited by 437 · see citing works

Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease

Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 430 · see citing works

Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro

Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429 · see citing works

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427 · see citing works

Iron trafficking inside the brain

Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 421 · see citing works

Potential oxidative pathways of brain catecholamines

Tse, D. C. S., McCreery, R. L., & Adams, R. N. (1976) · Journal of Medicinal Chemistry · doi:10.1021/jm00223a008 · Cited by 415 · cited 3× · see citing works

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409 · see citing works

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

Pakkenberg, B., Møller, A., Gundersen, H. J. G., Dam, A. M., & Pakkenberg, H. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.30 · Cited by 408 · see citing works

Iron, Neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00186.x · Cited by 401 · see citing works

New trends in photobiology

Sarna, T. (1992) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/1011-1344(92)85027-r · Cited by 396 · see citing works

Role of semiconductivity and ion transport in the electrical conduction of melanin

Mostert, A. B., Powell, B. J., Pratt, F. L., Hanson, G. R., Sarna, T., Gentle, I., & Meredith, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119948109 · Cited by 379 · see citing works

An update on iron physiology

Múñoz, M., Villar, I., & García‐Erce, J. A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4617 · Cited by 371 · see citing works

Inflammation alters the expression of <scp>DMT</scp> 1, <scp>FPN</scp> 1 and hepcidin, and it causes iron accumulation in central nervous system cells

Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M., González‐Billault, C., & Núñez, M. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12244 · Cited by 364 · see citing works

Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase

Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359 · see citing works

The relevance of iron in the pathogenesis of Parkinson’s disease

Sian‐Hülsmann, J., Mandel, S. A., Youdim, M. B. H., & Riederer, P. F. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 349 · see citing works

Advanced Chemical Methods in Melanin Determination

Wakamatsu, K., & Ito, S. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02017.x · Cited by 347 · see citing works

Microglia in the Aging Brain

Conde, J. R., & Streit, W. J. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000202887.22082.63 · Cited by 344 · see citing works

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

Baez, S., Segura‐Aguilar, J., Widersten, M., Johansson, A.-S., & Mannervik, B. (1997) · Biochemical Journal · doi:10.1042/bj3240025 · Cited by 340 · see citing works

MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338 · see citing works

Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease

Wilms, H., Rosenstiel, P. C., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337 · see citing works

Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease

Rouault, T. A. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009019 · Cited by 332 · see citing works

Free radical scavenging properties of melanin

Rôżanowska, M., Sarna, T., Land, E. J., & Truscott, T. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00234-2 · Cited by 328 · see citing works

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains

Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020717.x · Cited by 317 · cited 2× · see citing works

Neuronal vulnerability, pathogenesis, and Parkinson's disease

Sulzer, D. L., & Surmeier, D. J. (2012) · Movement Disorders · doi:10.1002/mds.25095 · Cited by 315 · see citing works

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · see citing works

Iron (III) induces aggregation of hyperphosphorylated τ and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease

Yamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., & Kitamoto, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.t01-1-01061.x · Cited by 313 · see citing works

Mechanisms of Brain Iron Transport: Insight into Neurodegeneration and CNS Disorders

Mills, E., Dong, X.-P., Wang, F., & Xu, H. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.09.140 · Cited by 309 · see citing works

Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease

Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303 · see citing works

Kinetic and Structural Analysis of the Early Oxidation Products of Dopamine

Bisaglia, M., Mammi, S., & Bubacco, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610893200 · Cited by 303 · see citing works

Structure, function, and mechanism of ribonucleotide reductases

Kolberg, M. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(04)00054-8 · Cited by 298 · see citing works

Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin

D’Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296 · see citing works

The Red and the Black

Simon, J. D., & Peles, D. N. (2010) · Accounts of Chemical Research · doi:10.1021/ar100079y · Cited by 296 · see citing works

α‐Synuclein oligomers and clinical implications for Parkinson disease

Kalia, L. V., Kalia, S. K., McLean, P. J., Lozano, A. M., & Lang, A. E. (2012) · Annals of Neurology · doi:10.1002/ana.23746 · Cited by 295 · see citing works

Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals

Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440612 · Cited by 295 · see citing works

THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION AND NEURAL DEGENERATION

Liu, Y., & Edwards, R. H. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.125 · Cited by 295 · see citing works

Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease

House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294 · see citing works

Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease

Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06358.x · Cited by 287 · see citing works

The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

Zecca, L., Fariello, R. G., Riederer, P. F., Sulzer, D. L., Gatti, A., & Tampellini, D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03269-0 · Cited by 287 · see citing works

Intraneuronal dopamine-quinone synthesis: a review

Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284 · see citing works

Interactions of melanin with metal ions. Electron spin resonance evidence for chelate complexes of metal ions with free radicals

Felix, C. C., Hyde, J. S., Sarna, T., & Sealy, R. C. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00480a044 · Cited by 284 · see citing works

Brain Iron Metabolism

Rouault, T. A., & Cooperman, S. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.002 · Cited by 280 · see citing works

Wilson Disease

Taly, A. B., Meenakshi‐Sundaram, S., Sinha, S., Swamy, H. S., & Arunodaya, G. R. (2007) · Medicine · doi:10.1097/md.0b013e318045a00e · Cited by 278 · see citing works

Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations

Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H., & Lee, V. M.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412621200 · Cited by 273 · see citing works

Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System

Bradbury, M. W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020443.x · Cited by 270 · see citing works

Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics

Zecca, L., Zucca, F. A., Wilms, H., & Sulzer, D. L. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.009 · Cited by 265 · see citing works

Sequestration of iron by Lewy bodies in Parkinson's disease

Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010050001 · Cited by 265 · see citing works

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease

Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264 · see citing works

Loss of melanin from human RPE with aging: possible role of melanin photooxidation

Sarna, T., Burke, J. M., Korytowski, W., Rôżanowska, M., Skumatz, C. M. B., Zaręba, A., & Zaręba, M. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00247-6 · Cited by 263 · see citing works

Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity

Lopes, K. O., Sparks, D. L., & Streit, W. J. (2008) · Glia · doi:10.1002/glia.20678 · Cited by 262 · see citing works

Decreased ferritin levels in brain in Parkinson's disease

Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258 · see citing works

Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257 · see citing works

Protein degradation pathways in Parkinson’s disease: curse or blessing

Ebrahimi‐Fakhari, D., Wahlster, L., & McLean, P. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1004-6 · Cited by 255 · see citing works

Molecular Anatomy of Tyrosinase and its Related Proteins: Beyond the Histidine‐Bound Metal Catalytic Center

García-Borrón, J. C., & Solano, F. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02012.x · Cited by 251 · see citing works

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1994) · Annals of Neurology · doi:10.1002/ana.410360612 · Cited by 251 · see citing works

Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., & Shimohama, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 246 · see citing works

Iron (III) induces aggregation of hyperphosphorylated τ and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease

Yamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., YOSHIMASU, F., & Kitamoto, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01061.x · Cited by 246 · see citing works

Brain iron metabolism and its perturbation in neurological diseases

Crichton, R. R., Dexter, D. T., & Ward, R. J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 246 · see citing works

Inorganic Biochemistry of Iron Metabolism: From Molecular Mechanisms to Clinical Consequences

Crichton, R. R. (2001) · Cited by 244 · see citing works

Neuromelanin of the Human Substantia Nigra: An Update

Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9435-y · Cited by 243 · see citing works

Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine

Burke, W. J., Kumar, V. B., Pandey, N., Panneton, W. M., Gan, Q., Franko, M. W., Odell, M., Li, S. W., Pan, Y., Chung, H. D., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0303-9 · Cited by 243 · see citing works

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals

Zecca, L., Bellei, C., Costi, P., Albertini, A., Monzani, E., Casella, L., Gallorini, M., Bergamaschi, L., Moscatelli, A., Turro, N. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808768105 · Cited by 240 · see citing works

Dopamine, 6-hydroxydopamine, iron, and dioxygen — their mutual interactions and possible implication in the development of Parkinson's disease

Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K. A., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238 · see citing works

Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior

Youdim, M. B. H., Ben‐Shachar, D., & Yehuda, S. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.3.607 · Cited by 238 · see citing works

Brain iron metabolism: Neurobiology and neurochemistry

Ke, Y., & Qian, Z. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236 · see citing works

Phenylalanine hydroxylase: Function, structure, and regulation

Flydal, M. I., & Martı́nez, A. (2013) · IUBMB Life · doi:10.1002/iub.1150 · Cited by 236 · see citing works

Oxidative DNA damage and nucleotide excision repair

Melis, J. P. M., van Steeg, H., & Luijten, M. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.5036 · Cited by 234 · see citing works

Neuromelanin can protect against iron‐mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease

Zecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Żądło, A. C., Szewczyk, G. M., Zaręba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233 · see citing works

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease

Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229 · see citing works

Iron in the basal ganglia in Parkinson's disease

Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229 · see citing works

4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies

Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229 · see citing works

Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content?

Kästner, A., Hirsch, É. C., Lejeune, O., Javoy-Agid, F., Rascol, O., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08350.x · Cited by 228 · see citing works

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227 · see citing works

Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes

Ramos, P., Santos, A., Pinto, N. R., Mendes, R., Magalhães, T., & Almeida, A. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.08.001 · Cited by 221 · see citing works

Blood vessels change in the mesencephalon of patients with Parkinson's disease

Faucheux, B. A., Agid, Y., Hirsch, É. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218 · see citing works

The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson??s Disease

Jellinger, K. A. (1999) · Drugs &amp; Aging · doi:10.2165/00002512-199914020-00004 · Cited by 218 · see citing works

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.

Faucheux, B. A., Nillesse, N., Damier, P., Spik, G., Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J., & Agid, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9603 · Cited by 218 · see citing works

Parkinson’s disease: premotor clinico-pathological correlations

Wolters, E. C., & Braak, H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_47 · Cited by 216 · see citing works

Dopamine Oxidation and Autophagy

Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J. (2012) · Parkinson's Disease · doi:10.1155/2012/920953 · Cited by 214 · see citing works

Cellular management of iron in the brain

Connor, J. R., & Menzies, S. L. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00206-h · Cited by 213 · see citing works

Possible role of neuromelanin in the pathogenesis of Parkinson's disease

Mann, D. M. A., & Yates, P. O. (1983) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(83)90074-x · Cited by 211 · see citing works

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease

Goldstein, D. S., Sullivan, P., Holmes, C. S., Miller, G. W., Alter, S. P., Strong, R., Mash, D. C., Kopin, I. J., & Sharabi, Y. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12345 · Cited by 206 · see citing works

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205 · see citing works

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain

Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., & Swartz, H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00047-4 · Cited by 197 · see citing works

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

Mastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195 · see citing works

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter

Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194 · see citing works

The fundamental unit of synthetic melanin: a verification by tunneling microscopy of X-ray scattering results

Zajac, G. W., Gallas, J. M., Cheng, J., Eisner, M., Moss, S. C., & Alvarado-Swaisgood, A. E. (1994) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(94)90006-x · Cited by 193 · see citing works

On the mechanism of the Mn3+-induced neurotoxicity of dopamine: Prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase

Segura‐Aguilar, J., & Lind, C. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90006-9 · Cited by 192 · see citing works

Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease

Sulzer, D., Mosharov, E. V., Tallóczy, Z., Zucca, F. A., Simon, J. D., & Zecca, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05385.x · Cited by 190 · see citing works

EPIDERMAL "TURNOVER TIME"—A RE-EXAMINATION

Halprin, K. M. (1972) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1972.tb01886.x · Cited by 189 · see citing works

An ERcentric view of Parkinson's disease

Mercado, G., Valdés, P., & Hetz, C. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.005 · Cited by 185 · see citing works

Neuronal vulnerability, pathogenesis, and Parkinson's disease

Sulzer, D., & Surmeier, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25187 · Cited by 184 · see citing works

Iron-binding characteristics of neuromelanin of the human substantia nigra

Double, K. L., Gerlach, M., Schünemann, V., TRAUTWEIN, A. X., Zecca, L., Gallorini, M., Youdim, M. B. H., Riederer, P. F., & Ben‐Shachar, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00293-4 · Cited by 182 · see citing works

α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro

Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 181 · see citing works

Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging

Ortega, R., Cloetens, P., Devès, G., Carmona, A., & Bohic, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000925 · Cited by 178 · see citing works

Comparison of Structural and Chemical Properties of Black and Red Human Hair Melanosomes¶

Liu, Y., Hong, L., Wakamatsu, K., Ito, S., Adhyaru, B. B., Cheng, C., Bowers, C. R., & Simon, J. D. (2005) · Photochemistry and Photobiology · doi:10.1562/2004-08-03-ra-259.1 · Cited by 173 · see citing works

The structure of neuromelanin as studied by chemical degradative methods

Wakamatsu, K., Fujikawa, K., Zucca, F. A., Zecca, L., & Ito, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01917.x · Cited by 172 · see citing works

Pathogenic implications of iron accumulation in multiple sclerosis

Williams, R., Buchheit, C., Berman, N. E., & LeVine, S. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07536.x · Cited by 171 · see citing works

Ion-Exchange in Melanin: An Electron Spin Resonance Study with Lanthanide Probes

Sarna, T., Hyde, J. S., & Swartz, H. M. (1976) · Science · doi:10.1126/science.179142 · Cited by 170 · see citing works

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

Goldstein, D. S., Kopin, I. J., & Sharabi, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.006 · Cited by 168 · see citing works

Characterization of a novel brain‐derived microglial cell line isolated from neonatal rat brain

Cheepsunthorn, P., Radov, L. A., Menzies, S. L., Reid, J., & Connor, J. R. (2001) · Glia · doi:10.1002/glia.1070 · Cited by 163 · see citing works

Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain

Zecca, L., Pietra, R., Goj, C., Mecacci, C., Radice, D., & Sabbioni, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031097.x · Cited by 163 · see citing works

The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface

Bush, W. D., Garguilo, J., Zucca, F. A., Albertini, A., Zecca, L., Edwards, G. S., Nemanich, R. J., & Simon, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604010103 · Cited by 159 · see citing works

The Role of Iron in Beta Amyloid Toxicity

Schubert, D. A., & Chevion, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2678 · Cited by 159 · see citing works

Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues

Bush, V. J., Moyer, T. P., Batts, K. P., & Parisi, J. E. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.284 · Cited by 156 · see citing works

Ion‐Exchange and Adsorption of Fe(III) by Sepia Melanin

Liu, Y., Hong, L., Kempf, V. R., Wakamatsu, K., Ito, S., & Simon, J. D. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00140.x · Cited by 153 · see citing works

Detection of 5-S-cysteinyldopamine in human brain

Rosengren, E., Linder-Eliasson, E., & Carlsson, A. (1985) · Journal of Neural Transmission · doi:10.1007/bf01252029 · Cited by 152 · see citing works

Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease

Gibb, W. R. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90719-p · Cited by 152 · see citing works

Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease

Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151 · see citing works

Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells

Laar, V. S. V., Mishizen-Eberz, A. J., Cascio, M., & Hastings, T. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.004 · Cited by 151 · see citing works

Aggregation and neurotoxicity of α-synuclein and related peptides

EI-Agnaf, O. M. A., & Irvine, G. B. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300559 · Cited by 151 · see citing works

α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease

Mullin, S., & Schapira, A. H. V. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8394-x · Cited by 151 · see citing works

Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration

Andersen, H. H., Johnsen, K. B., & Moos, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1509-8 · Cited by 151 · see citing works

X‐Ray Characterization of Melanins—I

Cheng, J. Q., Moss, S. C., Eisner, M., & Zschack, P. R. (1994) · Pigment Cell Research · doi:10.1111/j.1600-0749.1994.tb00060.x · Cited by 149 · see citing works

Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update

Napolitano, A., Manini, P., & d’Ischia, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795496863 · Cited by 149 · see citing works

Mobility Gaps: A Mechanism for Band Gaps in Melanins

McGinness, J. E. (1972) · Science · doi:10.1126/science.177.4052.896 · Cited by 147 · see citing works

X‐Ray Characterization of Melanins—II

Cheng, J. Q., Moss, S. C., & Eisner, M. (1994) · Pigment Cell Research · doi:10.1111/j.1600-0749.1994.tb00061.x · Cited by 147 · see citing works

Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides

Wakamatsu, K., Hu, D., McCormick, S. A., & Ito, S. (2007) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00415.x · Cited by 144 · see citing works

Neuromelanin and Parkinson's disease.

MARSDEN, C. D. (1983) · PubMed · Cited by 143 · see citing works

Iron deficiency: Differential effects on monoamine transporters

Burhans, M. S., Dailey, C., Beard, Z., Wiesinger, J. A., Murray‐Kolb, L. E., Jones, B. C., & Beard, J. L. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047070 · Cited by 143 · see citing works

The neuromelanin of the human substantia nigra

Carstam, R., Brinck, C., Hindemith, A., Rorsman, H., & Rosengren, E. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90100-n · Cited by 142 · see citing works

Altered monamine metabolism in caudate-putamen of iron-deficient rats

Beard, J. L., Chen, Q., Connor, J. R., & Jones, B. C. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90323-9 · Cited by 140 · see citing works

The effect of melanin on iron associated decomposition of hydrogen peroxide

Pilas, B., Sarna, T., Kalyanaraman, B., & Swartz, H. M. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90049-4 · Cited by 139 · see citing works

A potential pathogenetic role of iron in Alzheimer's disease

Silvestri, L., & Camaschella, C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00356.x · Cited by 139 · see citing works

Binding of Iron to Neuromelanin of Human Substantia Nigra and Synthetic Melanin: An Electron Paramagnetic Resonance Spectroscopy Study

Shima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135 · see citing works

Melanins, Melanogenesis and Melanocytes: Looking at Their Functional Significance from the Chemist's Viewpoint

Prota, G. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.2000.130412.x · Cited by 132 · see citing works

Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability

Zucca, F. A., Bellei, C., Giannelli, S. G., Terreni, M., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., & Zecca, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0453-2 · Cited by 132 · see citing works

Iron homeostasis in astrocytes and microglia is differentially regulated by TNF‐α and TGF‐β1

Rathore, K. I., Redensek, A., & David, S. (2012) · Glia · doi:10.1002/glia.22303 · Cited by 130 · see citing works

Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects

Segura‐Aguilar, J., Metodiewa, D., & Welch, C. J. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00036-1 · Cited by 130 · see citing works

Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases

Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Rahman, H. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,182 · see citing works

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,121 · see citing works

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859 · see citing works

The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain

Mather, M., & Harley, C. W. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2016.01.001 · Cited by 485 · see citing works

Determinants of dopaminergic neuron loss in Parkinson's disease

Surmeier, D. J. (2018) · FEBS Journal · doi:10.1111/febs.14607 · Cited by 455 · see citing works

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

Betts, M. J., Kirilina, E. P., Otaduy, M. C. G., Ivanov, D., Acosta‐Cabronero, J., Callaghan, M. F., Lambert, C., Cárdenas‐Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 349 · see citing works

The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases

Kausar, S., Wang, F., & Cui, H. (2018) · Cells · doi:10.3390/cells7120274 · Cited by 315 · see citing works

Iron in Neurodegeneration – Cause or Consequence?

Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 298 · see citing works

Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms

Eid, R., Arab, N. T. T., & Greenwood, M. T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.12.002 · Cited by 286 · see citing works

Iron and dopamine: a toxic couple

Hare, D. J., & Double, K. L. (2016) · Brain · doi:10.1093/brain/aww022 · Cited by 284 · see citing works

Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care

Wang, Y., Spincemaille, P., Liu, Z., Dimov, A., Deh, K., Li, J., Zhang, Y., Yao, Y., Gillen, K. M., Wilman, A. H., et al. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25693 · Cited by 278 · see citing works

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

Sulzer, D. L., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J. A., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0047-3 · Cited by 277 · see citing works

Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases

Monzani, E., Nicolis, S., Dell’Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D. L., Zecca, L., & Casella, L. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 270 · see citing works

Metals and Neurodegeneration

Chen, P., Miah, M. R., & Aschner, M. (2016) · F1000Research · doi:10.12688/f1000research.7431.1 · Cited by 260 · see citing works

Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress

Garza-Lombó, C., Posadas, Y., Quintanar, L., Gonsebatt, M. E., & Franco, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7272 · Cited by 254 · see citing works

Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain

Cassidy, C., Zucca, F. A., Girgis, R. R., Baker, S. C., Weinstein, J. J., Sharp, M. E., Bellei, C., Valmadre, A., Vanegas‐Arroyave, N., Kegeles, L. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807983116 · Cited by 247 · see citing works

One-pot synthesis of Au-Cu2O/rGO nanocomposite based electrochemical sensor for selective and simultaneous detection of dopamine and uric acid

Aparna, T. K., Sivasubramanian, R., & Dar, M. A. (2018) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2018.01.205 · Cited by 246 · see citing works

Bioactivity of Olive Oil Phenols in Neuroprotection

Angeloni, C., Malaguti, M., Barbalace, M. C., & Hrelia, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112230 · Cited by 237 · see citing works

Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives

Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., & Smirnova, L. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8881770 · Cited by 252 · see citing works

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline

Jacobs, H. I. L., Becker, J. A., Kwong, K. K., Engels, N., Prokopiou, P. C., Papp, K. V., Properzi, M. J., Hampton, O. L., Uquillas, F. D., Sanchez, J. S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2511 · Cited by 222 · see citing works

Oxidative stress factors in Parkinson’s disease

Dorszewska, J., Kowalska, M., Prendecki, M., Piekut, T., Kozłowska, J., & Kozubski, W. P. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300980 · Cited by 211 · see citing works

Iron, myelin, and the brain: neuroimaging meets neurobiology

Möller, H. E., Bossoni, L., Connor, J. R., Crichton, R. R., Does, M. D., Ward, R. J., Zecca, L., Zucca, F. A., & Ronen, I. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.009 · Cited by 207 · see citing works

Calcium and Parkinson's disease

Surmeier, D. J., Schumacker, P. T., Guzmán, J. D., Ilijić, E., Yang, B., & Zampese, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.168 · Cited by 203 · see citing works

Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions

Dovonou, A., Bolduc, C., Linan, V. S., Gora, C., Peralta, M. R., & Lévesque, M. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00368-8 · Cited by 203 · see citing works

Parkinson's Disease Is Not Simply a Prion Disorder

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 186 · see citing works

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain

Gąsiorowska, A., Wydrych, M., Drapich, P., Zadrożny, M., Steczkowska, M., Niewiadomski, W., & Niewiadomska, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654931 · Cited by 192 · see citing works

Injectable hydrogel based on quaternized chitosan, gelatin and dopamine as localized drug delivery system to treat Parkinson’s disease

Ren, Y., Zhao, X., Liang, X., Ma, P. X., & Guo, B. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.130 · Cited by 188 · see citing works

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease

Biondetti, E., Santin, M. D., Valabrègue, R., Mangone, G., Gaurav, R., Pyatigorskaya, N., Hutchison, M., Yahia‐Cherif, L., Villain, N., Habert, M., et al. (2021) · Brain · doi:10.1093/brain/awab191 · Cited by 186 · see citing works

Neurotoxicity of Metal Mixtures

Andrade, V. M., Aschner, M., & dos Santos, A. P. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_12 · Cited by 180 · see citing works

In vivo MRI assessment of the human locus coeruleus along its rostrocaudal extent in young and older adults

Betts, M. J., Cárdenas‐Blanco, A., Kanowski, M., Jessen, F., & Düzel, E. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.09.042 · Cited by 165 · see citing works

Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature

Nebrisi, E. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011248 · Cited by 165 · see citing works

The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease

Matchett, B. J., Grinberg, L. T., Theofilas, P., & Murray, M. E. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02248-1 · Cited by 162 · see citing works

The Aging of Iron Man

Ashraf, A., Clark, M., & So, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158 · see citing works

Cerebral Iron Deposition in Neurodegeneration

Dušek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159 · see citing works

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 154 · see citing works

Contrast mechanisms associated with neuromelanin‐MRI

Trujillo, P., Summers, P. E., Ferrari, E., Zucca, F. A., Sturini, M., Mainardi, L. T., Cerutti, S., Smith, A. K., Smith, S. A., Zecca, L., et al. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26584 · Cited by 154 · see citing works

Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s disease

Zucca, F. A., Vanna, R., Cupaioli, F. A., Bellei, C., Palma, A. D., Silvestre, D. D., Mauri, P., Grassi, S., Prinetti, A., Casella, L., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0050-8 · Cited by 152 · see citing works

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease

Vila, M. (2019) · Movement Disorders · doi:10.1002/mds.27776 · Cited by 147 · see citing works

Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies

Ma, L., Azad, M. G., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 148 · see citing works

Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease

Duda, J., Pötschke, C., & Liss, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13572 · Cited by 149 · see citing works

Multilevel Impacts of Iron in the Brain: The Cross Talk between Neurophysiological Mechanisms, Cognition, and Social Behavior

Ferreira, A. C. E., Neves, P., & Gozzelino, R. (2019) · Pharmaceuticals · doi:10.3390/ph12030126 · Cited by 148 · see citing works

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective

Derry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 142 · see citing works

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase

Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S., & Wakamatsu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084176 · Cited by 142 · see citing works

Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration

Zhang, S., Wang, R., & Wang, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00454 · Cited by 133 · see citing works

Iron deposition in Parkinson’s disease by quantitative susceptibility mapping

Chen, Q., Chen, Y., Zhang, Y., Wang, F., Yu, H., Zhang, C., Jiang, Z., & Luo, W. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0505-9 · Cited by 133 · see citing works

Iron chelation in the treatment of neurodegenerative diseases

Dušek, P., Schneider, S. A., & Aaseth, J. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.03.010 · Cited by 133 · see citing works

Development, wiring and function of dopamine neuron subtypes

Garritsen, O., van Battum, E. Y., Grossouw, L. M., & Pasterkamp, R. J. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00669-3 · Cited by 128 · see citing works

Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis

studygroups, T. F.-I. A. F.-I., Devos, D., Cabantchik, Z. I., Moreau, C., Danel-Brunaud, V., Mahoney‐Sanchez, L., Bouchaoui, H., Gouel, F., Rolland, A., Duce, J. A., et al. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-019-02138-1 · Cited by 132 · see citing works

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Zarkali, A., Thomas, G. E. C., Zetterberg, H., & Weil, R. S. (2024) · Nature Communications · doi:10.1038/s41467-024-49949-9 · Cited by 128 · see citing works

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain

Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 126 · see citing works

Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro

Yauger, Y. J., Bermudez, S., Moritz, K. E., Glaser, E. P., Stoica, B. A., & Byrnes, K. R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1430-7 · Cited by 125 · see citing works

Role of iron in neurodegenerative diseases

Li, K., & Reichmann, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1508-7 · Cited by 117 · see citing works

α-Synuclein in Parkinson’s disease: causal or bystander?

Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T. H., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 118 · see citing works

Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator

Haining, R. L., & Achat‐Mendes, C. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202928 · Cited by 116 · see citing works

Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease

Cheng, Z., He, N., Huang, P., Li, Y., Tang, R., Sethi, S. K., Ghassaban, K., Yerramsetty, K. K., Palutla, V. K., Chen, S., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102103 · Cited by 114 · see citing works

The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson’s Disease

Weng, M., Xie, X., Liu, C., Lim, K., Zhang, C., & Li, L. (2018) · Parkinson s Disease · doi:10.1155/2018/9163040 · Cited by 114 · see citing works

Maturation of the human striatal dopamine system revealed by PET and quantitative MRI

Larsen, B., Olafsson, V., Calabro, F., Laymon, C., Tervo-Clemmens, B., Campbell, E., Minhas, D., Montez, D., Price, J., & Luna, B. (2020) · Nature Communications · doi:10.1038/s41467-020-14693-3 · Cited by 107 · see citing works

The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols

Aryal, S., Skinner, T., Bridges, B., & Weber, J. T. (2020) · Molecules · doi:10.3390/molecules25194382 · Cited by 109 · see citing works

Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker

Gaurav, R., Yahia‐Cherif, L., Pyatigorskaya, N., Mangone, G., Biondetti, E., Valabrègue, R., Ewenczyk, C., Hutchison, R. M., Cedarbaum, J. M., Corvol, J., et al. (2021) · Movement Disorders · doi:10.1002/mds.28531 · Cited by 107 · see citing works

Redox Signaling in Neurotransmission and Cognition During Aging

Kumar, A., Yegla, B., & Foster, T. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7111 · Cited by 104 · see citing works

Polydopamine Nanoparticles Prepared Using Redox-Active Transition Metals

Salomäki, M., Ouvinen, T., Marttila, L., Kivelä, H., Leiro, J. A., Mäkilä, E. M., & Lukkari, J. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b11994 · Cited by 102 · see citing works

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l -DOPA delivery in the 6-OHDA model of Parkinson's disease

Mulas, G., Espa, E., Fenu, S., Spiga, S., Cossu, G., Pillai, E., Carboni, E., Simbula, G., Jadzic, D., Angius, F., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.09.013 · Cited by 103 · see citing works

Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI

Xing, Y., Sapuan, A. H., Dineen, R. A., & Auer, D. P. (2018) · Movement Disorders · doi:10.1002/mds.27502 · Cited by 103 · see citing works

The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease

Liss, B., & Striessnig, J. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021214 · Cited by 103 · see citing works

The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration

Mor, D. E., Daniels, M. J., & Ischiropoulos, H. (2019) · Movement Disorders · doi:10.1002/mds.27607 · Cited by 103 · see citing works

Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease

García‐Pardo, J., Novio, F., Nador, F., Cavaliere, I., Suárez–García, S., Lope‐Piedrafita, S., Candiota, A. P., Romero‐Giménez, J., Rodríguez-Galván, B., Bové, J., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c00453 · Cited by 103 · see citing works

Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement–Induced Parkinson’s Disease in Experimental Rats

Sharma, S., Aran, K. R., & Singh, S. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00120-z · Cited by 102 · see citing works

Longitudinal Development of Brain Iron Is Linked to Cognition in Youth

Larsen, B., Bourque, J., Moore, T. M., Adebimpe, A., Calkins, M., Elliott, M., Gur, R., Gur, R., Moberg, P., Roalf, D., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2434-19.2020 · Cited by 92 · see citing works

Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease

Wang, Y., Gao, L., Chen, J., Li, Q., Huo, L., Wang, Y., Wang, H., & Du, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.757161 · Cited by 106 · see citing works

Iron homeostasis imbalance and ferroptosis in brain diseases

Long, H.-N., Zhu, W.-S., Wei, L.-M., & Zhao, J.-G. (2023) · MedComm · doi:10.1002/mco2.298 · Cited by 108 · see citing works

Redox active metals in neurodegenerative diseases

Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 101 · see citing works

Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases

Novellino, F., Saccà, V., Donato, A., Zaffino, P., Spadea, M. F., Vismara, M. F. M., Arcidiacono, B., Malara, N., Presta, I., & Donato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031115 · Cited by 104 · see citing works

Melanin: insights into structure, analysis, and biological activities for future development

Song, W. F., Yang, H., Liu, S., Yu, H., Li, D., Li, P., & Xing, R. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01132a · Cited by 101 · see citing works

Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease

Surmeier, D. J., Halliday, G. M., & Simuni, T. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.001 · Cited by 99 · see citing works

MRI biomarkers of motor and non-motor symptoms in Parkinson's disease

Ryman, S. G., & Poston, K. L. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.10.002 · Cited by 98 · see citing works

Manipulating the Sensitivity and Selectivity of OECT‐Based Biosensors via the Surface Engineering of Carbon Cloth Gate Electrodes

Xi, X., Wu, D., Ji, W., Zhang, S., Tang, W., Su, Y., Guo, X., & Liu, R. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905361 · Cited by 97 · see citing works

Brain Iron Accumulation in Atypical Parkinsonian Syndromes: in vivo MRI Evidences for Distinctive Patterns

Lee, J., & Lee, M. S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00074 · Cited by 95 · see citing works

Ferritinophagy‐Mediated Ferroptosis Involved in Paraquat‐Induced Neurotoxicity of Dopaminergic Neurons: Implication for Neurotoxicity in PD

Zuo, Y., Xie, J., Li, X., Li, Y., Thirupathi, A., Zhang, J., Yu, P., Gao, G., Chang, Y., & Shi, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9961628 · Cited by 95 · see citing works

Global Research Trends of Ferroptosis: A Rapidly Evolving Field With Enormous Potential

Wu, H., Wang, Y., Tong, L., Yan, H., & Sun, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.646311 · Cited by 93 · see citing works

Brain Iron Metabolism, Redox Balance and Neurological Diseases

Gao, G., You, L., Zhang, J. J., Chang, Y., & Yu, P. (2023) · Antioxidants · doi:10.3390/antiox12061289 · Cited by 90 · see citing works

A facile preparation of Au—SiO2 nanocomposite for simultaneous electrochemical detection of dopamine and uric acid

Immanuel, S., Aparna, T. K., & Sivasubramanian, R. (2018) · Surfaces and Interfaces · doi:10.1016/j.surfin.2018.11.010 · Cited by 87 · see citing works

Parkinson's disease: From bench to bedside

Draoui, A., Hiba, O. E., Aimrane, A., Khiat, A. E., & Gamrani, H. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.11.002 · Cited by 82 · see citing works

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease

Minakaki, G., Krainc, D., & Burbulla, L. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580634 · Cited by 83 · see citing works

Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases

Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 81 · see citing works

Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons

Sun, J., Lin, X., Lu, D.-H., Wang, M., Li, K., Li, S., Li, Z., Zhu, C., Zhang, Z.-M., Yan, C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165228 · Cited by 82 · see citing works

Natural melanin pigments and their interfaces with metal ions and oxides: emerging concepts and technologies

Mauro, E. D., Xu, R., Soliveri, G., & Santato, C. (2017) · MRS Communications · doi:10.1557/mrc.2017.33 · Cited by 81 · see citing works

Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited

Langley, J. A., Huddleston, D. E., Merritt, M. D., Chen, X., McMurray, R., Silver, M., Factor, S. A., & Hu, X. P. (2016) · Human Brain Mapping · doi:10.1002/hbm.23192 · Cited by 78 · see citing works

Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease

Duce, J. A., Wong, B. X. W., Durham, H., Devedjian, J.-C., Smith, D. P., & Devos, D. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0186-8 · Cited by 80 · see citing works

Uses, misuses, new uses and fundamental limitations of magnetic resonance imaging in cognitive science

Turner, R. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0349 · Cited by 78 · see citing works

Magnetic resonance imaging of noradrenergic neurons

Watanabe, T., Tan, Z., Wang, X., Martinez-Hernandez, A., & Frahm, J. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01858-0 · Cited by 77 · see citing works

Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite

Bruning, J. M., Wang, Y., Oltrabella, F., Tian, B., Kholodar, S. A., Liu, H., Bhattacharya, P., Guo, S., Holton, J. M., Fletterick, R. J., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.002 · Cited by 78 · see citing works

Highly sensitive and selective dopamine biosensor using Au nanoparticles-ZnO nanocone arrays/graphene foam electrode

Yue, H., Zhang, H., Huang, S., Lu, X. X., Gao, X., Song, S. S., Wang, Z., Wang, W. Q., & Guan, E. H. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110490 · Cited by 76 · see citing works

l ‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?

Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T. T., Pillai, E., Fisone, G., Raisman‐Vozari, R., & Bel, E. A. D. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13482 · Cited by 76 · see citing works

Lactoferrin as a nutraceutical protein from milk, an overview

Iglesias-Figueroa, B. F., Espinoza-Sánchez, E. A., Siqueiros-Cendón, T., & Rascón-Cruz, Q. (2018) · International Dairy Journal · doi:10.1016/j.idairyj.2018.09.004 · Cited by 76 · see citing works

Promoting endothelial cell affinity and antithrombogenicity of polytetrafluoroethylene (PTFE) by mussel-inspired modification and RGD/heparin grafting

Mi, H., Jing, X., Thomsom, J. A., & Turng, L. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00654g · Cited by 75 · see citing works

Diabetes Mellitus as a Risk Factor for Parkinson’s Disease: a Molecular Point of View

Biosa, A., Outeiro, T. F., Bubacco, L., & Bisaglia, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1025-9 · Cited by 74 · see citing works

Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system

Martín‐Bastida, A., Lao–Kaim, N. P., Roussakis, A., Searle, G. E., Xing, Y., Gunn, R. N., Schwarz, S. T., Barker, R. A., Auer, D. P., & Piccini, P. P. (2019) · Brain · doi:10.1093/brain/awz120 · Cited by 73 · see citing works

The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance

Dahl, M. J., Bachman, S. L., Dutt, S., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., Werkle‐Bergner, M., & Mather, M. (2023) · Nature Aging · doi:10.1038/s43587-023-00469-z · Cited by 73 · see citing works

Parkinson’s Disease: The Mitochondria-Iron Link

Muñoz, Y., Carrasco, C. M., Campos, J., Aguirre, P., & Núñez, M. T. (2016) · Parkinson s Disease · doi:10.1155/2016/7049108 · Cited by 73 · see citing works

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint

Kaindlstorfer, C., Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiß, G., & Wenning, G. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170601 · Cited by 71 · see citing works

Neuromelanin can protect against iron‐mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease

Zecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Żądło, A. C., Szewczyk, G. M., Zaręba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233 · see citing works

Single-cell quantification of the iron-neuromelanin balance in dopaminergic neurons across the lifespanPreprint

Büttner, F., Reinert, T., Jäger, C., Brammerloh, M., Morawski, M., Lipp, I., Falkenberg, G., Brückner, D., McElreath, R., Crockford, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.08.721830

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease

Gerlach, M., Double, K. L., Ben‐Shachar, D., Zecca, L., Youdim, M. B. H., & Riederer, P. F. (2003) · Neurotoxicity Research · doi:10.1007/bf03033371 · Cited by 112 · see citing works

The enigma of neuromelanin in Parkinson's disease substantia nigra.

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1994) · PubMed · Cited by 70 · see citing works

Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?

Kienzl, E., Jellinger, K. A., Stachelberger, H., & Linert, W. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00458-0 · Cited by 62 · see citing works